NSC |
Compound |
Enrichment |
Correlation |
NSC 697653 |
Null |
3.6295237294955e-006 |
0.35772694 |
NSC 382035 |
2,4-Pyrimidinediamine, 6-ethyl-5-[4-[methyl(phenylmethyl) amino]-3-nitrophenyl]- |
3.88440367201721e-005 |
0.86387956 |
NSC 753221 |
3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline |
4.18332145614864e-005 |
0.55593166 |
NSC 615441 |
1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride |
4.88335076207314e-005 |
0.63608314 |
NSC 710204 |
Null |
4.88335076207314e-005 |
0.45677431 |
NSC 740 |
Methotrexate |
4.93279880911877e-006 |
0.93801699 |
NSC 112846 |
N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid |
6.70485325419773e-005 |
0.84616877 |
NSC 694485 |
Benzoic acid, 4-[[(2,4-diaminopteridinyl)-6-methyl] (formyl)amino]- |
6.70485325419777e-005 |
0.5776866 |
NSC 696921 |
Null |
6.70485325419777e-005 |
0.22234715 |
NSC 752464 |
methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate |
6.70485325419777e-005 |
0.40812165 |